TrueScale Capitals leads Series B2 funding for Advamedica
Boston, 27th July 2021: Advamedica has raised $6 million in a Series B2 funding round led by TrueScale
Advamedica Receives FDA Clearance for Axiostat Hemostatic Patch
A biomaterial-focused MedTech startup has announced FDA 510(k) clearance of its hemostatic product...
Advamedica selected to pitch for Medtech Innovator US Military Pitch
Advamedica has been selected for MedTech Innovator US Military Pitch (May 2020) to pitch its Military...
Omidyar Network leads Series B1 funding for Advamedica
Advamedica has raised $5.2 Mn in Series B1 round of funding led by Omidyar Network, along with participation...
Advamedica announces world-class scientific advisory board
Advamedica has announced its top-notch scientific advisory board and research collaboration...
Axiostat receives US FDA clearance
US FDA granted 510(k) clearance to Axiostat Chitosan Hemostatic Dressing, which is cleared...
University of California Series B round of funding for Advamedica
Advamedica has raised $7.4 million Series B funding led by UC-RNT fund -- set up by the University...